The effect of oral administration of Withania somnifera root on formalin-induced pain in diabetic rats

Abstract  Introduction: Hyperalgesia is considered as one the marked signs of subchronic diabetes mellitus that could affect the life style of the patients. With c onsidering the potential anti-diabetic effect of the medicinal plant Withania somnifera (WS)( ashwagandha), this study was designed to i...

Full description

Bibliographic Details
Main Author: Mohsen Khalili
Format: Article
Language:English
Published: Iran University of Medical Sciences 2009-01-01
Series:Basic and Clinical Neuroscience
Subjects:
Rat
Online Access:http://bcn.iums.ac.ir/browse.php?a_code=A-10-1-7&slc_lang=en&sid=1
id doaj-7cdbaf8576b94ecab7b56fe2184146ab
record_format Article
spelling doaj-7cdbaf8576b94ecab7b56fe2184146ab2020-11-25T02:43:58ZengIran University of Medical SciencesBasic and Clinical Neuroscience2008-126X2228-74422009-01-01112931The effect of oral administration of Withania somnifera root on formalin-induced pain in diabetic ratsMohsen Khalili0 Abstract  Introduction: Hyperalgesia is considered as one the marked signs of subchronic diabetes mellitus that could affect the life style of the patients. With c onsidering the potential anti-diabetic effect of the medicinal plant Withania somnifera (WS)( ashwagandha), this study was designed to investigate the analgesic effect of WS on formalin-induced nociceptive responses (standard formalin test) in diabetic rats. Methods: Rats were divided into control, WS-treated control, diabetic, sodium salicylate (SS)-treated control and diabetic and WS-treated diabetic groups. For induction of diabetes, streptozotocin (STZ) was used at a single dose. The treatment groups received oral administration of ashwagandha -mixed rat pellet (6.25%) for two months.  Results: The results showed that diabetic rats exhibited a higher score of pain at both phases of the formalin test and WS-treated diabetic rats exhibited a lower nociceptive score at both phases of the test (p<0.05). Meanwhile, SS administration significantly reduced pain score only at chronic phase of the test in the diabetic group (p<0.01).   Discussion: Taken together, these results indicate that two-month administration of ashwagandha could attenuate nociceptive score in an experimental model of diabetes mellitus and this may be considered as a potential treatment for painful diabetic neuropathy.http://bcn.iums.ac.ir/browse.php?a_code=A-10-1-7&slc_lang=en&sid=1Withania somnifera Analgesia Diabetes mellitus Streptozotocin Rat
collection DOAJ
language English
format Article
sources DOAJ
author Mohsen Khalili
spellingShingle Mohsen Khalili
The effect of oral administration of Withania somnifera root on formalin-induced pain in diabetic rats
Basic and Clinical Neuroscience
Withania somnifera
Analgesia
Diabetes mellitus
Streptozotocin
Rat
author_facet Mohsen Khalili
author_sort Mohsen Khalili
title The effect of oral administration of Withania somnifera root on formalin-induced pain in diabetic rats
title_short The effect of oral administration of Withania somnifera root on formalin-induced pain in diabetic rats
title_full The effect of oral administration of Withania somnifera root on formalin-induced pain in diabetic rats
title_fullStr The effect of oral administration of Withania somnifera root on formalin-induced pain in diabetic rats
title_full_unstemmed The effect of oral administration of Withania somnifera root on formalin-induced pain in diabetic rats
title_sort effect of oral administration of withania somnifera root on formalin-induced pain in diabetic rats
publisher Iran University of Medical Sciences
series Basic and Clinical Neuroscience
issn 2008-126X
2228-7442
publishDate 2009-01-01
description Abstract  Introduction: Hyperalgesia is considered as one the marked signs of subchronic diabetes mellitus that could affect the life style of the patients. With c onsidering the potential anti-diabetic effect of the medicinal plant Withania somnifera (WS)( ashwagandha), this study was designed to investigate the analgesic effect of WS on formalin-induced nociceptive responses (standard formalin test) in diabetic rats. Methods: Rats were divided into control, WS-treated control, diabetic, sodium salicylate (SS)-treated control and diabetic and WS-treated diabetic groups. For induction of diabetes, streptozotocin (STZ) was used at a single dose. The treatment groups received oral administration of ashwagandha -mixed rat pellet (6.25%) for two months.  Results: The results showed that diabetic rats exhibited a higher score of pain at both phases of the formalin test and WS-treated diabetic rats exhibited a lower nociceptive score at both phases of the test (p<0.05). Meanwhile, SS administration significantly reduced pain score only at chronic phase of the test in the diabetic group (p<0.01).   Discussion: Taken together, these results indicate that two-month administration of ashwagandha could attenuate nociceptive score in an experimental model of diabetes mellitus and this may be considered as a potential treatment for painful diabetic neuropathy.
topic Withania somnifera
Analgesia
Diabetes mellitus
Streptozotocin
Rat
url http://bcn.iums.ac.ir/browse.php?a_code=A-10-1-7&slc_lang=en&sid=1
work_keys_str_mv AT mohsenkhalili theeffectoforaladministrationofwithaniasomniferarootonformalininducedpainindiabeticrats
AT mohsenkhalili effectoforaladministrationofwithaniasomniferarootonformalininducedpainindiabeticrats
_version_ 1724768317215866880